{"id":"W4397007234","doi":"10.1016/j.esmoop.2024.103146","title":"159TiP TROPION-Breast04: Phase (ph) III study of neoadjuvant (neoadj) datopotamab deruxtecan (Dato-DXd) + durvalumab (D) followed by adjuvant (adj) D vs standard of care (SoC) in treatment-naïve, triple-negative (TN) and HR-low/HER2- breast cancer (BC)","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Standard of care; Adjuvant; Oncology; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000174892,0.0006680817,0.001302388,0.0001645726,0.0001726315,0.00009715144,0.0005375466,0.0002044456,0.0001701364],"category_scores_gemma":[0.0000328538,0.0005551671,0.0001961331,0.0004132313,0.000280881,0.0000538625,0.0006017243,0.0001786031,0.000003429801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003878837,"about_ca_system_score_gemma":0.000554526,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05585494,"about_ca_topic_score_gemma":0.0436115,"domain_scores_codex":[0.9967888,0.0002347448,0.0008104117,0.00121424,0.0004015418,0.00055027],"domain_scores_gemma":[0.9984241,0.00007920351,0.000298401,0.000757289,0.0002557575,0.0001852087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.08781601,0.01949728,0.3107587,0.001687531,0.0156741,0.001095021,0.056434,0.0002261738,0.03132366,0.0002751515,0.01624551,0.4589668],"study_design_scores_gemma":[0.2353181,0.04120668,0.2776604,0.003733252,0.00421944,0.0003904306,0.08219665,0.0002997801,0.330446,0.000288645,0.02007595,0.004164681],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830936,0.006634812,0.00002398928,0.000552145,0.0003028653,0.002629656,0.006164648,0.00003003667,0.0005682392],"genre_scores_gemma":[0.9959574,0.001769638,0.0001198444,0.00004106629,0.00009713979,0.0007428244,0.0005778738,0.00009151811,0.0006027267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4548021,"threshold_uncertainty_score":0.99969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009822913088877542,"score_gpt":0.3140747849802658,"score_spread":0.3042518718913882,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}